Clofutriben Pharmacokinetics in Patients With Impaired Renal Function

Clinical trial NCT07227922 · RECRUITING

Trial details

NCT number: NCT07227922
Sponsor: Sparrow Pharmaceuticals
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Moderate Renal Impairment

Start date: 2025-11-30
Primary completion: 2026-04-30
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.